400
Participants
Start Date
April 26, 2021
Primary Completion Date
April 30, 2031
Study Completion Date
April 30, 2031
Patient with Soft Tissue Sarcoma
"* Tumor specimens will be collected for the study at diagnosis.~* A blood sample will be collected in all included patients at baseline, after the completion of the treatment (for patients included with a localized disease) or at the time of the first tumoral evaluation (for patients included with a metastatic disease), and at the time of progression.~* Patient's data (clinical, biological and disease data) will also be collected at baseline visit and then at each time point planned in the center for clinical benefit assessment (i.e. every 2 or 3 months) until progression or for a maximum duration of 5 years."
WITHDRAWN
Institut Paoli-Calmettes, Marseille
RECRUITING
Chu Besancon - Site Jean Minjoz, Besançon
WITHDRAWN
Institut de Cancerologie de L'Ouest - Site Rene Gauducheau, Saint-Herblain
RECRUITING
Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy
RECRUITING
Centre Oscar Lambret, Lille
RECRUITING
Centre Jean Perrin, Clermont-Ferrand
RECRUITING
Centre Leon Berard, Lyon
WITHDRAWN
Institut Gustave Roussy, Villejuif
RECRUITING
Institut Bergonié, Bordeaux
RECRUITING
Institut Bergonié, Bordeaux
RECRUITING
Centre Georges François Leclerc, Dijon
RECRUITING
Chu Dupuytren, Limoges
RECRUITING
Chu de Marseille - Hopital de La Timone, Marseille
RECRUITING
Hôpital Cochin - Site Port-Royal, Paris
RECRUITING
Institut Curie, Paris
RECRUITING
Chu Poitiers, Poitiers
RECRUITING
Institut Godinot, Reims
RECRUITING
Centre Eugene Marquis, Rennes
RECRUITING
Institut de Cancérologie Strasbourg Europe, Strasbourg
RECRUITING
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse
RECRUITING
Centre Antoine Lacassagne, Nice
Institut Claudius Regaud
OTHER